Literature DB >> 9167258

Botulinum toxin: the story of its development for the treatment of human disease.

E J Schantz1, E A Johnson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9167258     DOI： 10.1353/pbm.1997.0032

Source DB:  PubMed          Journal:  Perspect Biol Med        ISSN： 0031-5982            Impact factor:   1.416


× No keyword cloud information.
  14 in total

1.  High-affinity, protective antibodies to the binding domain of botulinum neurotoxin type A.

Authors:  D D Pless; E R Torres; E K Reinke; S Bavari
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

Review 2.  From poison to remedy: the chequered history of botulinum toxin.

Authors:  F J Erbguth
Journal:  J Neural Transm (Vienna)       Date:  2007-04-26       Impact factor: 3.575

3.  Medical treatment of benign prostatic hyperplasia.

Authors:  Herbert Lepor
Journal:  Rev Urol       Date:  2011

4.  Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E.

Authors:  Michael R Baldwin; William H Tepp; Christina L Pier; Marite Bradshaw; Mengfei Ho; Brenda A Wilson; Robert B Fritz; Eric A Johnson; Joseph T Barbieri
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

Review 5.  Botulinum toxin injections for treating neurogenic detrusor overactivity.

Authors:  Ömer Bayrak; Erkan Sadioğlu; Rahmi Onur
Journal:  Turk J Urol       Date:  2015-12

Review 6.  Botulinum Toxin Use for Modulating Neuroimmune Cutaneous Activity in Psoriasis.

Authors:  Marius Nicolae Popescu; Cristina Beiu; Mădălina Gabriela Iliescu; Mara Mădălina Mihai; Liliana Gabriela Popa; Ana Maria Alexandra Stănescu; Mihai Berteanu
Journal:  Medicina (Kaunas)       Date:  2022-06-16       Impact factor: 2.948

Review 7.  [Botulinum toxin in urology. An inventory].

Authors:  H Schulte-Baukloh; H H Knispel
Journal:  Urologe A       Date:  2004-08       Impact factor: 0.639

Review 8.  Use of botulinum toxin A in adult neurological disorders: efficacy, tolerability and safety.

Authors:  Wilhelm J Schulte-Mattler
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

9.  Botulinum toxin - From WMD to therapeutic agent and cosmetic aid.

Authors:  Roger M Pinder
Journal:  Neuropsychiatr Dis Treat       Date:  2007-12       Impact factor: 2.570

10.  Intraprostatic botulinum toxin injection in patients with benign prostatic enlargement.

Authors:  Cristian P Ilie; Michael B Chancellor; Yao-Chi Chuang; Mischianu Dan
Journal:  J Med Life       Date:  2009 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.